Every Form 4 that Bunge Global SA (BG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BG filings page.
Bunge Global SA director reported a small equity award under the company’s long-term incentive plans. On December 1, 2025, the reporting person acquired 18 shares of common stock at a price of $96.47 per share through restricted stock units credited via a dividend feature. After this transaction, the director beneficially owned 8,783 shares directly. This filing reflects routine equity-based compensation rather than an open-market purchase or sale.
Bunge Global SA director reported a small equity award related to their existing holdings. On 12/01/2025, the insider acquired 15 shares of common stock at $96.47 per share through restricted stock units credited under a dividend feature in the company's long-term incentive plans. Following this routine transaction, the reporting person beneficially owned 7,197 shares directly. This reflects ongoing participation in Bunge's equity-based compensation and dividend programs rather than an open-market purchase or sale.
Bunge Global SA director reports a small equity award. A company director acquired 34 shares of Bunge Global SA common stock on December 1, 2025 as restricted stock units with a value reference of $96.47 per share, granted under the company’s long-term incentive plans through a dividend feature. After this transaction, the director beneficially owns 21,871 shares directly and 6,500 shares indirectly through the Zenuk Family Living Trust u/a/d 09/01/2015.
Bunge Global SA (BG) reported an insider transaction by its Executive VP, Global Markets. On 11/21/2025, the officer exercised stock options to acquire 5,300 shares of common stock at an exercise price of $50.07 per share and then sold shares on the same day.
The reported sales included 5,300 shares of common stock at a weighted average price of $94.3823 per share (from trades between $94.30 and $94.48) and an additional 20,000 shares at a weighted average price of $94.3709 per share (from trades between $94.28 and $94.44). After these transactions, the officer beneficially owned 104,536.808 shares of Bunge Global SA common stock directly.
The derivative position reported was a stock option (right to buy) for 5,300 shares at $50.07, which was exercised on 11/21/2025, leaving 0 such derivative securities owned. The option had become exercisable in three equal annual installments beginning on March 1, 2017.